General MedicationsORALStandard

VENLAFAXINE HYDROCHLORIDE

Standard Dose

EQ 50MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview VENLAFAXINE HYDROCHLORIDE is listed in Drugs@FDA under application 206250 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient VENLAFAXINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 50MG BASE Sponsor CADILA PHARMS LTD Submission history Latest submission status date: 2023-08-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview VENLAFAXINE HYDROCHLORIDE is listed in Drugs@FDA under application 206250 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VENLAFAXINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 50MG BASE Sponsor CADILA PHARMS LTD Submission history Latest submission status date: 2023-08-18 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.